Prop 65 Smoking Cessation Warnings Not In Conflict With FDA Rules – Court
This article was originally published in The Tan Sheet
Executive Summary
FDA's newly revised pregnancy warning for OTC smoking cessation products could be expanded to include a statement regarding fetal harm as required under Proposition 65, a San Francisco appellate judge says
You may also be interested in...
CHPA Weighs In As Prop 65 Amicus Brief Filed In Calif. Supreme Court
The Consumer Healthcare Products Association's amicus curiae brief in defense of nicotine-replacement therapy manufacturers involved in California Prop 65 litigation reflects the group's concern the labeling conflict involved could extend to other OTC drugs
CHPA Weighs In As Prop 65 Amicus Brief Filed In Calif. Supreme Court
The Consumer Healthcare Products Association's amicus curiae brief in defense of nicotine-replacement therapy manufacturers involved in California Prop 65 litigation reflects the group's concern the labeling conflict involved could extend to other OTC drugs
CHPA Weighs In As Prop 65 Amicus Brief Filed In Calif. Supreme Court
The Consumer Healthcare Products Association's amicus curiae brief in defense of nicotine-replacement therapy manufacturers involved in California Prop 65 litigation reflects the group's concern the labeling conflict involved could extend to other OTC drugs